EU Clinical Trial Information System (CTIS)

Brand Logo

Brand Logo Light

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

The purpose of the investigation is to confirm the safety and efficacy in long-term use of Symbicort Turbuhaler in patients with Chronic obstructive pulmonary disease (COPD) under the post-marketing actual use.

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for long-term use for Chronic obstructive pulmonary disease (COPD) patients

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for long-term use for COPD patients

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for long-term use for Chronic obstructive pulmonary disease (COPD) patients

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Documents available

CSR Synopsis

Protocol redacted

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator